Pharmacokinetics of Ceftriaxone Free Fraction
NCT05061875 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 20
Last updated 2021-11-17
Summary
Prospective observational follow-up study for the study and modeling of the pharmacokinetics of the free fraction of ceftriaxone in patients treated with high doses of ceftriaxone (greater than or equal to 4 grams per day).
Conditions
- Ceftriaxone Poisoning
Sponsors & Collaborators
-
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
lead OTHER
Principal Investigators
-
Maria Victoria Gil Navarro · Hospitales Universitarios Virgen del Rocío
Eligibility
- Min Age
- 55 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-03-01
- Primary Completion
- 2022-02-01
- Completion
- 2022-02-01
Countries
- Spain
Study Locations
More Related Trials
-
Safety and Efficacy Study of Ceftaroline Versus a Comparator in Pediatric Subjects With Complicated Community Acquired Pneumonia (CABP)
NCT01669980 ·Status: COMPLETED ·Phase: PHASE4
-
Cefazolin Pharmacokinetics: Elimination Clearance in Neonates
NCT01295606 ·Status: COMPLETED ·Phase: PHASE4
-
Pharmacokinetics of Caspofungin
NCT03399032 ·Status: COMPLETED
-
Evaluation of the Pharmacokinetics of Caspofungin in ICU Patients
NCT02596984 ·Status: COMPLETED ·Phase: NA
-
Crossover Study to Compare the Pharmacokinetics of Subcutaneous and Intravenous Ceftriaxone Administration
NCT02561442 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Pharmacokinetics of Flucloxacillin Given by Continuous or Intermittent Infusion to ICU Patients
NCT02993575 ·Status: COMPLETED
-
Population Pharmacokinetics of Amikacin in Neonates
NCT04867135 ·Status: COMPLETED
-
Cefazolin PK Study 3g vs 2g
NCT05309304 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetics of Antibiotics in Critically Ill Patients Receiving CVVHF
NCT04800952 ·Status: UNKNOWN ·Phase: NA
-
Pharmacokinetic Study,Ceftobiprole,Healthy Volunteers,Healthy Patients With End Stage Renal Disease
NCT01030731 ·Status: COMPLETED ·Phase: PHASE1
-
A Single-Dose Pharmacokinetics and Safety Study of Ceftobiprole in Pediatric Patients =3 Months to <18 Years of Age
NCT01026636 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Efficacy Study of Ceftaroline Versus a Comparator in Pediatric Subjects With Community Acquired Bacterial Pneumonia (CABP)
NCT01530763 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Plasma and Abscess Fluid Pharmacokinetics of Cefpirome and Moxifloxacin After Single and Multiple Dose Administration
NCT00280514 ·Status: COMPLETED ·Phase: PHASE4
-
Pharmacokinetics of Bolus Versus Continuous Cefazolin Infusion in Patients Undergoing Major Surgery
NCT02058979 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Pharmacokinetic and Pharmacodynamic Properties of Intravenous Colistimethate Sodium
NCT02288429 ·Status: COMPLETED
-
Safety and Therapeutic Drug Monitoring of Cefazolin in Continuous Renal Replacement Therapy
NCT03672149 ·Status: UNKNOWN ·Phase: PHASE1
-
Antibiotic Prophylaxis in Pediatric Open Fractures
NCT06055712 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE4
-
Study of Repeated Cefoxitin Administration in Major Abdominal Surgery Using a Microdialysis Technique
NCT02703857 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety Study of Short-term Antibiotic for Pyelonephritis in Women
NCT01390623 ·Status: COMPLETED ·Phase: PHASE4
-
Prolonged Infusion Cefepime and Nosocomial Infections
NCT02568800 ·Status: UNKNOWN ·Phase: PHASE3
-
A Placebo-Controlled, Dose-Escalating Study to Examine the Safety and Tolerability of Single Intravenous Doses of CF-301 in Healthy Subjects
NCT02439359 ·Status: COMPLETED ·Phase: PHASE1
-
Population Pharmacokinetic-pharmacodynamic (PK-PD) Study of 9 Broad-Spectrum Anti-infective Agents in the Cerebro Spinal Fluid (CSF) of Brain Injured Patients With an External Ventricular Drainage (EVD).
NCT03481569 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetics of Ceftazidime-avibactam Among Critically-ill Patients Receiving CVVHDF
NCT04358991 ·Status: COMPLETED
-
Colistin Pharmacokinetics in Critically Ill Patients During Extended Dialysis
NCT02556190 ·Status: COMPLETED
-
Pharmacokinetics and Safety of Ticarcillin-clavulanate in Infants
NCT01229046 ·Status: WITHDRAWN ·Phase: PHASE1